Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric Disorders
Journal of Pharma Insights and Research October 5, 2025 M Loganathan, A Saravanakumar, P. Parthiban et al.
Psilocybin, an indoleamine alkaloid derived from various fungal species, is the subject of renewed, rigorous investigation for its therapeutic potential in psychiatry. This compound, a prodrug for the active metabolite psilocin, functions primarily as a partial agonist at the serotonin 2A (5-HT2A) receptor. Its administration within a structured psychotherapeutic context is associated with...
DOI: 10.69613/thv1dn30 (opens in new tab)
Default mode network
Psilocybin
Neuroplasticity
Context archaeology
+12